Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Timber Pharmaceuticals, Inc. | CEO & Chairman | Common Stock, par value $0.001 per share | 70.8K | $115K | $1.63 | Aug 20, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TMBR | Timber Pharmaceuticals, Inc. | Aug 20, 2023 | 1 | $0 | 4 | Aug 22, 2023 | CEO & Chairman |
TMBR | Timber Pharmaceuticals, Inc. | Apr 15, 2023 | 1 | $0 | 4 | Apr 18, 2023 | CEO & Chairman |
TMBR | Timber Pharmaceuticals, Inc. | Apr 15, 2022 | 1 | $0 | 4 | Apr 19, 2022 | CEO & Chairman of the Board, Director |
TMBR | Timber Pharmaceuticals, Inc. | Dec 15, 2021 | 1 | $7.69K | 4 | Dec 16, 2021 | CEO & President, Director |
TMBR | Timber Pharmaceuticals, Inc. | Sep 14, 2021 | 1 | $0 | 4 | Sep 16, 2021 | CEO & President, Director |